# Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia

> **NCT04453384** · PHASE2 · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 416 (actual)

## Conditions studied

- SARS Virus

## Interventions

- **DRUG:** XAV-19
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04453384
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-01
- **Primary completion:** 2021-05-21
- **Final completion:** 2021-08-19
- **Target enrollment:** 416 (ACTUAL)
- **Last updated:** 2022-03-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04453384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04453384, "Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04453384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*